Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis

doi:10.4251/wjgo.v12.i11.1346

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7091)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-3) series.

Item

Count

PDF

445

WORD

218

HTML

2923

Figures (1-9)

185

Tables (1-3)

187

Sum=3958

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

555

Download

625

Sum=1180

Publishing Process of This Article

Item

Count

Browse

620

Download

1333

Sum=1953

Nov 15, 2020 (publication date) through Apr 29, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastrointest Oncol. Nov 15, 2020; 12(11): 1346-1363
Published online Nov 15, 2020. doi: 10.4251/wjgo.v12.i11.1346

Table 3 P values of Begg and Egger's tests

Test	ORR	DCR	6-mo OS	6-mo PFS	12-mo OS	12-mo PFS	AEs	Grade ≥ 3 AEs
Begg’s P value	0.669	0.945	0.452	0.902	0.161	0.734	0.583	0.760
Egger’s P value	0.973	0.890	0.810	0.448	0.015	0.821	0.924	0.992

ORR: Objective response rate; DCR: Disease control rate; OS: Overall survival; PFS: Progression-free survival; AEs: Adverse events.

Citation: Yang L, Dong XZ, Xing XX, Cui XH, Li L, Zhang L. Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis. World J Gastrointest Oncol 2020; 12(11): 1346-1363
URL: https://www.wjgnet.com/1948-5204/full/v12/i11/1346.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i11.1346